Effect of Helfer Skin Tap and Cold Application on Pain and Hemodynamics During Vaccination
Comparison of the Effects of the Helfer Skin Tap Technique and Local Cold Application on Pain and Hemodynamic Parameters During Vaccination in Pregnant Women
Celal Bayar University
90 participants
May 9, 2025
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to investigate the effect of local cold application using the Helfer Skin Tap Technique on pain levels during the intramuscular injection of the tetanus vaccine in pregnant women. The study will also record vital signs, which are among the physiological effects of pain.
Eligibility
Inclusion Criteria5
- Over the age of 18,
- Scheduled to receive a tetanus vaccine,
- Able to speak and communicate in Turkish,
- Willing to participate in the study,
- Not experiencing any pain for any reason prior to the injection.
Exclusion Criteria11
- Under the age of 18,
- Received a tetanus vaccine for reasons other than pregnancy,
- Received a vaccine other than tetanus,
- Experiencing pain for any reason prior to the vaccine,
- Have circulatory disorders or peripheral vascular disease,
- Have bleeding or clotting disorders,
- Have a local infection,
- Used painkillers at least 6 hours prior to the procedure,
- Underwent a painful procedure within the last hour,
- Have cold sensitivity,
- Have cognitive or psychological issues.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
In the first phase of the study, pregnant women who agree to participate and meet the sampling criteria will be informed about the study, and their written and verbal consents will be obtained. Then, the "Individual Identification Form" will be completed. In the second phase, the vital signs of the pregnant women will be measured by the nurse involved in the study. Following this, tetanus vaccination will be administered to the pregnant women in the intervention group using the Helfer Skin Tap technique in accordance with the "Helfer Skin Tap IM Injection Procedure Guideline". In the third phase of the study, pain will be assessed using the Numerical Pain Scale immediately after the procedure and 15 minutes later by the nurse, and the vital signs of the pregnant women will be measured again. To evaluate the long-term effects of pain, participants will be contacted via a link, and pain assessments will be conducted at the 24th and 48th hours following the vaccination.
In the first phase of the study, pregnant women who agree to participate and meet the sampling criteria will be informed about the study, and their written and verbal consents will be obtained. Then, the "Individual Identification Form" will be completed. In the second phase, the vital signs of the pregnant women will be measured by the nurse involved in the study. Subsequently, tetanus vaccination will be administered to the pregnant women in the intervention group using a cold compress gel, based on the "Cold Compress Gel IM Injection Procedure Guideline" developed in line with the relevant literature. In the third phase of the study, pain will be assessed using the Numerical Pain Scale immediately after the procedure and 15 minutes later by nurse, and the vital signs of the pregnant women will be measured again. Pain assessment will be repeated at the 24th and 48th hours following the vaccination.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06976632